Andrea Scarpino

ORCID: 0000-0003-3287-6210
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Click Chemistry and Applications
  • Chemical Synthesis and Analysis
  • Protein Degradation and Inhibitors
  • Computational Drug Discovery Methods
  • Peptidase Inhibition and Analysis
  • Monoclonal and Polyclonal Antibodies Research
  • Poetry Analysis and Criticism
  • Ubiquitin and proteasome pathways
  • CAR-T cell therapy research
  • Multiple Myeloma Research and Treatments
  • Advanced Biosensing Techniques and Applications
  • Advanced biosensing and bioanalysis techniques
  • RNA modifications and cancer
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Financial Reporting and Valuation Research
  • Literature, Film, and Journalism Analysis
  • Caching and Content Delivery
  • Empathy and Medical Education
  • Advancements in Semiconductor Devices and Circuit Design
  • Modular Robots and Swarm Intelligence
  • Web visibility and informetrics
  • Financial Markets and Investment Strategies
  • Muscle metabolism and nutrition
  • DNA and Biological Computing
  • HER2/EGFR in Cancer Research

Institute of Cancer Research
2023-2025

HUN-REN Research Centre for Natural Sciences
2018-2021

Budapest University of Economics and Business
2020

Medicina
2020

University of Pisa
2018

University of Bari Aldo Moro
2014

Marist College
2014

American Heart Association
1993

Increased interest in covalent drug discovery led to the development of computer programs predicting binding mode and affinity inhibitors. Here we compare performance six docking tools, AutoDock4, CovDock, FITTED, GOLD, ICM-Pro, MOE, for reproducing experimental modes an unprecedently large diverse set complexes. It was found that 40–60% top scoring ligand poses are within 2.0 Å RMSD from mode. This rate showed program dependent increase achieved 50–90% when best among ten considered. is...

10.1021/acs.jcim.8b00228 article EN Journal of Chemical Information and Modeling 2018-06-11

Immunomodulatory drug (IMiD) resistance is a key clinical challenge in myeloma treatment. Previous data suggests almost one third of patients acquire mutations the IMiD effector cereblon by time they are pomalidomide refractory. Some events, including stop codons/frameshift and copy loss, having clearly explicable effects on function. Missense have also been reported throughout length but their functional impact has not systematically studied. This study modelled selected missense examined...

10.1182/blood.2024025861 article EN cc-by-nc-nd Blood 2025-01-22

Here we present WIDOCK, a virtual screening protocol that supports the selection of diverse electrophiles as covalent inhibitors by incorporating ligand reactivity towards cysteine residues into AutoDock4. WIDOCK applies reactive docking method (Backus et al. in Nature 534:570-574, 2016) and extends it tool introducing facile experimental or computational parametrization focused evaluation scheme together with retrospective prospective validation against various therapeutically relevant...

10.1007/s10822-020-00371-5 article EN cc-by Journal of Computer-Aided Molecular Design 2021-01-18

Abstract Small molecules inducing protein degradation are important pharmacological tools to interrogate complex biology and rapidly translating into clinical agents. However, fully realise the potential of these molecules, selectivity remains a limiting challenge. Herein, we addressed issue in design CRL4 CRBN recruiting PROteolysis TArgeting Chimeras (PROTACs). Thalidomide derivatives used generate PROTACs have well described intrinsic monovalent profiles by recruitment neo‐substrates,...

10.1002/cbic.202300351 article EN cc-by ChemBioChem 2023-07-07

To address the limitation associated with degron based systems, we have developed iTAG, a synthetic tag on IMiDs/CELMoDs mechanism of action that improves and addresses limitations both PROTAC previous IMiDs/CeLMoDs tags. Using structural sequence analysis, systematically explored native chimeric containing domains (DCDs) evaluated their ability to induce degradation. We identified optimal iTAG(DCD23 60aa) elicits robust degradation targets across cell types subcellular localizations without...

10.1016/j.isci.2023.107059 article EN cc-by iScience 2023-06-07

Thanks to recent guidelines, the design of safe and effective covalent drugs has gained significant interest. Other than targeting non-conserved nucleophilic residues, optimizing noncovalent binding framework is important improve potency selectivity binders toward desired target. Significant efforts have been made in extending computational toolkits include a mechanism protein targeting, like development docking methods for mode prediction. To highlight value complex process, here we...

10.1002/cmdc.201900078 article EN cc-by ChemMedChem 2019-02-20

A virtual screening workflow for fragment-sized kinase inhibitors is presented, along with a newly identified and validated hinge binder fragment.

10.1039/c9md00519f article EN cc-by-nc RSC Medicinal Chemistry 2020-01-01

Dietary, anthropometric, and chronic disease risk factors (CDRF) including blood lipids pressure (BP), were measured in 91 vitamin-mineral supplement users (SU) nonusers (NU) representing a wide range of athletic interests. Supplements used by 46 (51%) subjects; 100% female athletes 51% male supplements while none group 15 control subjects currently supplements. Both dietary intake energy expenditure using 7-day records. Adiposity was determined from body weight, mass index, skinfolds. Total...

10.1080/07315724.1993.10718297 article EN Journal of the American College of Nutrition 1993-04-01

Large-scale virtual screening of boronic acid derivatives was performed to identify nonpeptidic covalent inhibitors the β5i subunit immunoproteasome. A hierarchical cascade including noncovalent and docking steps applied a library over 104,000 compounds. Then, 32 hits were selected, out which five experimentally confirmed. Biophysical biochemical tests showed micromolar binding affinity time-dependent inhibitory potency for two These results validate computational protocol that allows large...

10.3390/molecules24142590 article EN cc-by Molecules 2019-07-16

Background: Human lactate dehydrogenase 5 (hLDH5) represents a promising anticancer target, particularly for the treatment of hypoxic tumors, where it is often hyperexpressed. In fact, by catalyzing reduction pyruvate to lactate, hLDH5 allows survival tumor cells under conditions means glycolysis. Despite efforts dedicated identification and development inhibitors, only few compounds showing activity in cancer cell lines have been reported. Objective: present study, we developed virtual...

10.2174/1573407213666170208102317 article EN Current Bioactive Compounds 2018-06-12

Abstract Alternative splicing is a molecular mechanism that allows single gene to encode multiple proteins. It complex and highly controlled process used regulate normal expression but often dysregulated in cancer. Compounds can modulate alternative are currently being explored as potential new class of therapeutic agent This highlights the need for deeper understanding process, its regulation, impact. The discovery novel specific tool compounds would therefore not only be beneficial...

10.1158/1538-7445.am2024-2058 article EN Cancer Research 2024-03-22

This paper examines the implications of Sarbanes-Oxley on stock option backdating. The focus this research analyses previous literature both pre- and post-Sarbanes-Oxley. As presents, before SOX was implemented, reporting lag for grant filings increased degree opportunistic behaviours subsequently increasing likelihood establishment Sarbanes-Oxley, promoting trust transparency between companies their respective stakeholders, sets forth additional regulations mitigating issue In order to...

10.1504/ijea.2014.063735 article EN International Journal of Economics and Accounting 2014-01-01

Urban Decay Andrea Scarpino (bio) Small Enterprise Mary Biddinger Black Lawrence Press www.blacklawrence.com/small-enterprise/ 95 Pages; Print, $13.95 Dedicated “For the cities we left behind,” Biddinger’s fifth poetry collection, Enterprise, is both celebration and remembrance of urban life, especially for those who came age as our most prominent American began their decline. Fans work will recognize her crisply written lines surprising imagery, ability to make strange seemingly ordinary,...

10.1353/abr.2016.0068 article EN American book review/˜The œAmerican book review 2016-01-01

Final Gift Andrea Scarpino (bio) The Selected Poems of Donald Hall Houghton Mifflin Harcourt www.hmhco.com/shop/books 160 Pages; Print, $22.00 Full disclosure: it is exceedingly difficult to review a book like Hall. What there left say about Hall, whose work so many writers are intimately familiar with, who was the Poet Laureate United States from 2006 2007, has written more than fifty books poetry and prose, including biography, memoir, children’s books? And yet, manages something very few...

10.1353/abr.2016.0130 article EN American book review/˜The œAmerican book review 2016-01-01

Hover, and: 71 South Andrea Scarpino (bio) Hover The research shows that the self can be detached from body and live a phantom existence on its own, as in an out-of-body experience, or it felt outside of personal space, sense presence. –Dr. Peter Brugger, quoted New York Times Weeks before you died, told me you'd beenin hospital bed when your rise,hover near ceiling lights, heard name calledagain again. Probably doctors, I said,arranged flowers, get well cards. You shookyour head. were...

10.1353/psg.0.0343 article EN Prairie schooner 2009-12-01

State of Loss Andrea Scarpino (bio) System Ghosts Lindsay Tigue University Iowa Press www.uipress.uiowa.edu/books/2016-spring/system-ghosts.htm 84 Pages; Print, $19.95 Winner the 2015 Poetry Prize, Tigue's debut poetry collection is indeed filled with ghosts and feeling being haunted, sense that we live in a state continual loss. Ghosts, after all, are reminders people have lost who returned to tell stories from other side grave, settle scores, be sure remember they once lived we, too, will...

10.1353/abr.2017.0015 article EN American book review/˜The œAmerican book review 2017-01-01
Coming Soon ...